(Q68105426)
Statements
Anti-interleukin-2 receptor monoclonal antibody therapy induces anti-idiotypic antibodies in mice that block both in vitro and in vivo activity (English)
Pankewycz OG
Hassarjian R
Chang C
Strom TB
scientific article published on 01 April 1988